Anticancer efficiency of cycloartane triterpenoid derivatives isolated from Cimicifuga yunnanensis Hsiao on triple-negative breast cancer cells

References

• DischLForschKSiewertBDreweJFrickerGIn Vitro and In Situ Characterization of Triterpene Glycosides From Cimicifuga racemosa ExtractJ Pharm Sci2017106123642365028827038
   PubMed Web of Science ®Google Scholar
• YueGGXieSLeeJKNew potential beneficial effects of actein, a triterpene glycoside isolated from Cimicifuga species, in breast cancer treatmentSci Rep201663526327731376
   PubMed Web of Science ®Google Scholar
• NianYWangHYZhouLSuJLiYQiuMHCytotoxic cycloartane triterpenes of the traditional Chinese medicine “shengma” (Cimicifuga dahurica)Planta Med2013791606923225366
   PubMed Web of Science ®Google Scholar
• LiebermanSA review of the effectiveness of Cimicifuga racemosa (black cohosh) for the symptoms of menopauseJ Womens Health1998755255299650153
   PubMed Web of Science ®Google Scholar
• McKennaDJJonesKHumphreySHughesKBlack cohosh: efficacy, safety, and use in clinical and preclinical applicationsAltern Ther Health Med2001739310011347288
   PubMed Web of Science ®Google Scholar
• NianYZhangYLChenJCLuLQiuMHQingCCytotoxic chemical constituents from the roots of Cimicifuga foetida. [corrected]J Nat Prod2010732939820121210
   PubMed Web of Science ®Google Scholar
• ZhuNJiangYWangMHoCTCycloartane triterpene saponins from the roots of Cimicifuga foetidaJ Nat Prod200164562762911374958
   PubMed Web of Science ®Google Scholar
• SunLYanJNianYZhouLZhangHQiuMNew triterpene diglycosides from the rhizome of Cimifuga foetidaMolecules20081381712172118794781
   PubMed Web of Science ®Google Scholar
• LuLChenJCSongHJLiYNianYQiuMHFive new triterpene bisglycosides with acyclic side chains from the rhizomes of Cimicifuga foetida LChem Pharm Bull (Tokyo)201058572973320460805
   PubMed Web of Science ®Google Scholar
• YangQFengFZhangFLINE-1 ORF-1p functions as a novel HGF/ETS-1 signaling pathway co-activator and promotes the growth of MDA-MB-231 cellCell Signal201325122652266024012497
   PubMed Web of Science ®Google Scholar
• ZhangFFengFYangPFour-and-a-half-LIM protein 1 down-regulates estrogen receptor α activity through repression of AKT phosphorylation in human breast cancer cellInt J Biochem Cell Biol201244232032622094188
   PubMed Web of Science ®Google Scholar
• MaHYaoYWangCTranscription factor activity of estrogen receptor α activation upon nonylphenol or bisphenol A treatment enhances the in vitro proliferation, invasion, and migration of neuroblastoma cellsOnco Targets Ther201693451346327366082
   PubMed Web of Science ®Google Scholar
• JiaHYangQWangTRhamnetin induces sensitization of hepatocellular carcinoma cells to a small molecular kinase inhibitor or chemotherapeutic agentsBiochim Biophys Acta2016186071417143027091611
   PubMed Web of Science ®Google Scholar
• AnLLiDDChuHXTerfenadine combined with epirubicin impedes the chemo-resistant human non-small cell lung cancer both in vitro and in vivo through EMT and Notch reversalPharmacol Res201712410511528754458
   PubMed Web of Science ®Google Scholar
• LiLKangLZhaoWmiR-30a-5p suppresses breast tumor growth and metastasis through inhibition of LDHA-mediated Warburg effectCancer Lett2017400899828461244
   PubMed Web of Science ®Google Scholar
• ZhangYLiDJiangQNovel ADAM-17 inhibitor ZLDI-8 enhances the in vitro and in vivo chemotherapeutic effects of Sorafenib on hepatocellular carcinoma cellsCell Death Dis20189774329970890
   PubMed Web of Science ®Google Scholar
• ZhaoJBaiZFengFCross-talk between EPAS-1/HIF-2α and PXR signaling pathway regulates multi-drug resistance of stomach cancer cellInt J Biochem Cell Biol201672738826783937
   PubMed Web of Science ®Google Scholar
• LiangYXuXWangTThe EGFR/miR-338-3p/EYA2 axis controls breast tumor growth and lung metastasisCell Death Dis201787e292828703807
   PubMed Web of Science ®Google Scholar
• XuXFanZLiangCA signature motif in LIM proteins mediates binding to checkpoint proteins and increases tumour radiosensitivityNat Commun201781405928094252
   PubMed Web of Science ®Google Scholar
• XuXFanZKangLHepatitis B virus X protein represses miRNA-148a to enhance tumorigenesisJ Clin Invest2013123263064523321675
   PubMed Web of Science ®Google Scholar
• WuMZhaoGZhuangXTriclosan treatment decreased the antitumor effect of sorafenib on hepatocellular carcinoma cellsOnco Targets Ther2018112945295429849464
   PubMed Web of Science ®Google Scholar
• ShaoZLiYDaiWETS-1 induces Sorafenib-resistance in hepatocellular carcinoma cells via regulating transcription factor activity of PXRPharmacol Res201813518820030114438
   PubMed Web of Science ®Google Scholar
• XieHTianSYuHA new apatinib microcrystal formulation enhances the effect of radiofrequency ablation treatment on hepatocellular carcinomaOnco Targets Ther2018113257326529910621
   PubMed Web of Science ®Google Scholar
• WangDQYangCRStudies on the chemical constituents from Souliea VaginataNat Prod Res Dev1995714244
   Google Scholar
• LiCJChenDHXiaoPGChemical constituents of traditional Chinese drug “sheng-ma” (Cimicifuga dahurica)Yao Xue Xue Bao19932810777781 Chinese8009991
   PubMedGoogle Scholar
• KadotaSLiJXTanakaKNambaTConstituents of cimicifugae rhizoma II. Isolation and structures of new cycloartenol triterpenoids and related compounds from Cimicifuga foetida LTetrahedron199551411431166
   Web of Science ®Google Scholar
• CjLChemical constituents of Cimicifuga foetida LChinese Traditional and Herbal Drugs199526318288289 Chinese
   Google Scholar
• SunLRA New cycloartane Triterpenoid from the rhizome of Cimicifuga foetida Collected in DaliActa Botanica Yunnanica200527331336
   Google Scholar
• BansiLAn antilinflammatory active Furochromme, Norcimifugin from Cimicifuga foetida: Isolation, Characterization, total Synthesis and Anti-inflammatoryIndian J Chem1998379881893
   Google Scholar
• BabaKHataKKimuraYMatsuyamaYKozawaMChemical studies of Angelica japonica A. Gray. I. On the constituents of the ethyl acetate extract of the rootChem Pharm Bull198129925652570
   Web of Science ®Google Scholar
• SakuraiNInoueTNagaiMStudies on the Chinese crude drug “Shôma.” II. Triterpenes of Cimicifuga dahurica MaximYakugaku Zasshi1972926724728 Japanese5066374
   PubMedGoogle Scholar
• SakuraiNKimuraOInoueTNagaiMStudies on the Chinese crude drug “Shoma.” V. Structures of 24-O-acetylhydroshengmanol xyloside and 22-hydroxycimigenol xylosideChem Pharm Bull1981294955960
   Web of Science ®Google Scholar
• ChenSNFabricantDSLuZZFongHHFarnsworthNRCimiracemosides I-P, new 9,19-cyclolanostane triterpene glycosides from Cimicifuga racemosaJ Nat Prod200265101391139712398533
   PubMed Web of Science ®Google Scholar
• TangJJHeQRDongSDiversity Modification and Structure-Activity Relationships of Two Natural Products 1β-hydroxy Alantolactone and Ivangustin as Potent Cytotoxic AgentsSci Rep201881172229379131
   PubMedGoogle Scholar
• BaoFYangKWuCNew natural inhibitors of hexokinase 2 (HK2): Steroids from Ganoderma sinenseFitoterapia201812512312929305912
   PubMed Web of Science ®Google Scholar
• FujieAThe path to producing pharmaceuticals from natural products uncovered by academia-from the perspective of a science coordinatorBiosci Biotechnol Biochem2017811384227885934
   PubMed Web of Science ®Google Scholar
• MaffioliSIZhangYDegenDAntibacterial Nucleoside-Analog Inhibitor of Bacterial RNA PolymeraseCell2017169712401248.e2328622509
   PubMed Web of Science ®Google Scholar
• VargiuAVRamaswamyVKMalvacioIMallociGKleinekathöferURuggeronePWater-mediated interactions enable smooth substrate transport in a bacterial efflux pumpBiochimica Biophys Acta Gen Subj201818624836845
   PubMed Web of Science ®Google Scholar
• KimSWHasanuzzamanMdChoMRole of 14-3-3 sigma in over-expression of P-gp by rifampin and paclitaxel stimulation through interaction with PXRCell Signal20173112413428077325
   PubMed Web of Science ®Google Scholar
• McGuireJUtset-WardTJReedDRLynchCCRe-calculating! Navigating through the osteosarcoma treatment roadblockPharmacol Res2017117546427940205
   PubMed Web of Science ®Google Scholar
• XiaEZhouXBhandariAZhangXWangOSynaptopodin-2 plays an important role in the metastasis of breast cancer via PI3K/Akt/mTOR pathwayCancer Manag Res2018101575158330038517
   PubMed Web of Science ®Google Scholar
• ZhouJZhangWWPengFSunJYHeZYWuSGDownregulation of hsa_circ_0011946 suppresses the migration and invasion of the breast cancer cell line MCF-7 by targeting RFC3Cancer Manag Res20181053554429593432
   PubMed Web of Science ®Google Scholar
• HsiehEWangQZhangRVertebral fractures among breast cancer survivors in China: a cross-sectional study of prevalence and health services gapsBMC Cancer201818110429378534
   PubMedGoogle Scholar
• AghazadehSYazdanparastRActivation of STAT3/HIF-1α/Hes-1 axis promotes trastuzumab resistance in HER2-overexpressing breast cancer cells via down-regulation of PTENBiochim Biophys Acta Gen Subj2017186181970198028499822
   PubMed Web of Science ®Google Scholar
• VegaJFRamosJCruzVLMolecular and hydrodynamic properties of human epidermal growth factor receptor HER2 extracellular domain and its homodimer: Experiments and multi-scale simulationsBiochim Biophys Acta Gen Subj2017186192406241628642126
   PubMed Web of Science ®Google Scholar
• MishraRHankerABGarrettJTGenomic alterations of ERBB receptors in cancer: clinical implicationsOncotarget201786911437111439229371993
   PubMedGoogle Scholar
• BimonteSBarbieriACascellaMThe effects of naloxone on human breast cancer progression: in vitro and in vivo studies on MDA. MB231 cellsOnco Targets Ther20181118519129379300
   PubMed Web of Science ®Google Scholar
• CevatemreBErkısaMAztopalNA promising natural product, pristimerin, results in cytotoxicity against breast cancer stem cells in vitro and xenografts in vivo through apoptosis and an incomplete autophagy in breast cancerPharmacol Res201812950051429197639
   PubMed Web of Science ®Google Scholar
• HasanpourghadiMPanduranganAKMustafaMRModulation of oncogenic transcription factors by bioactive natural products in breast cancerPharmacol Res201812837638828923544
   PubMed Web of Science ®Google Scholar
• MarshLACarreraSShandilyaJBASP1 interacts with oestrogen receptor α and modifies the tamoxifen responseCell Death Dis201785e277128492543
   PubMedGoogle Scholar
• ZhangJZhouCJiangHZEB1 induces ER-α promoter hyper-methylation and confers antiestrogen resistance in breast cancerCell Death Dis201784e273228383555
   PubMedGoogle Scholar
• ShahNMohammadASSaralkarPInvestigational chemotherapy and novel pharmacokinetic mechanisms for the treatment of breast cancer brain metastasesPharmacol Res2018132476829604436
   PubMed Web of Science ®Google Scholar
• ReinertTBarriosCHOverall survival and progression-free survival with endocrine therapy for hormone receptor-positive, HER2-negative advanced breast cancer: reviewTher Adv Med Oncol201791169370929344106
   PubMed Web of Science ®Google Scholar
• PivotXBondarenkoINoweckiZPhase III, Randomized, Double-Blind Study Comparing the Efficacy, Safety, and Immunogenicity of SB3 (Trastuzumab Biosimilar) and Reference Trastuzumab in Patients Treated With Neoadjuvant Therapy for Human Epidermal Growth Factor Receptor 2-Positive Early Breast CancerJ Clin Oncol2018361096897429373094
   PubMed Web of Science ®Google Scholar
• AghazadehSYazdanparastRActivation of STAT3/HIF-1α/Hes-1 axis promotes trastuzumab resistance in HER2-overexpressing breast cancer cells via down-regulation of PTENBiochim Biophys Acta Gen Subj2017186181970198028499822
   PubMed Web of Science ®Google Scholar
• EvansMKSauerSJNathSRobinsonTJMorseMADeviGRX-linked inhibitor of apoptosis protein mediates tumor cell resistance to antibody-dependent cellular cytotoxicityCell Death Dis20167e207326821068
   PubMed Web of Science ®Google Scholar
• CentellesMNWrightMGedroycWThanouMFocused ultrasound induced hyperthermia accelerates and increases the uptake of anti-HER-2 antibodies in a xenograft modelPharmacol Res201611414415127771465
   PubMed Web of Science ®Google Scholar
• Madrid-ParedesACañadas-GarreMSánchez-PozoAABCB1 C3435T gene polymorphism as a potential biomarker of clinical outcomes in HER2-positive breast cancer patientsPharmacol Res201610811111827137881
   PubMed Web of Science ®Google Scholar
• GollamudiJParvaniJGSchiemannWPVinayakSNeoadjuvant therapy for early-stage breast cancer: the clinical utility of pertuzumabCancer Manag Res20168213126937204
   PubMed Web of Science ®Google Scholar
• XiongHYanTZhangWmiR-613 inhibits cell migration and invasion by downregulating Daam1 in triple-negative breast cancerCell Signal201844334229339084
   PubMed Web of Science ®Google Scholar